

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.56920186 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.21302689 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.21302689 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.18314845 |
| 5 | leukocyte aggregation (GO:0070486) | 4.65758934 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.60989360 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.58034702 |
| 8 | positive thymic T cell selection (GO:0045059) | 4.48693352 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.48080776 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.38942631 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.38942631 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.38942631 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.38942631 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.38942631 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 4.38942631 |
| 16 | negative T cell selection (GO:0043383) | 4.36778018 |
| 17 | negative thymic T cell selection (GO:0045060) | 4.36612710 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.31762450 |
| 19 | negative regulation of cell killing (GO:0031342) | 4.31762450 |
| 20 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.26475211 |
| 21 | response to peptidoglycan (GO:0032494) | 4.26090875 |
| 22 | detection of other organism (GO:0098543) | 4.23092884 |
| 23 | detection of bacterium (GO:0016045) | 4.22404362 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 4.16869392 |
| 25 | B cell receptor signaling pathway (GO:0050853) | 3.96107484 |
| 26 | mannose metabolic process (GO:0006013) | 3.93464639 |
| 27 | thymic T cell selection (GO:0045061) | 3.93148672 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 3.90642163 |
| 29 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.80057718 |
| 30 | regulation of B cell differentiation (GO:0045577) | 3.75637338 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.68972543 |
| 32 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.63025501 |
| 33 | response to interleukin-15 (GO:0070672) | 3.61503536 |
| 34 | negative regulation of phagocytosis (GO:0050765) | 3.59325046 |
| 35 | positive T cell selection (GO:0043368) | 3.55970776 |
| 36 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.53944338 |
| 37 | interferon-gamma production (GO:0032609) | 3.52186521 |
| 38 | T cell selection (GO:0045058) | 3.49786456 |
| 39 | detection of external biotic stimulus (GO:0098581) | 3.45792425 |
| 40 | T cell migration (GO:0072678) | 3.43128908 |
| 41 | regulation of mast cell degranulation (GO:0043304) | 3.41528841 |
| 42 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.36963321 |
| 43 | defense response to protozoan (GO:0042832) | 3.34340675 |
| 44 | positive regulation of B cell differentiation (GO:0045579) | 3.29763332 |
| 45 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.29490117 |
| 46 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.27911817 |
| 47 | cellular response to interleukin-15 (GO:0071350) | 3.27571890 |
| 48 | germinal center formation (GO:0002467) | 3.23521288 |
| 49 | regulation of leukocyte degranulation (GO:0043300) | 3.21884234 |
| 50 | leukocyte cell-cell adhesion (GO:0007159) | 3.17011118 |
| 51 | immunoglobulin mediated immune response (GO:0016064) | 3.16279570 |
| 52 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.12395263 |
| 53 | regulation of antigen processing and presentation (GO:0002577) | 3.12359577 |
| 54 | positive regulation of antigen processing and presentation (GO:0002579) | 3.09759222 |
| 55 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.09063253 |
| 56 | cellular extravasation (GO:0045123) | 3.08888823 |
| 57 | detection of biotic stimulus (GO:0009595) | 3.08278166 |
| 58 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.07445914 |
| 59 | cellular response to zinc ion (GO:0071294) | 3.05238027 |
| 60 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.05035166 |
| 61 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.04953542 |
| 62 | tolerance induction (GO:0002507) | 3.04328637 |
| 63 | response to type I interferon (GO:0034340) | 3.03704271 |
| 64 | response to protozoan (GO:0001562) | 3.02499719 |
| 65 | cellular response to type I interferon (GO:0071357) | 3.01659257 |
| 66 | type I interferon signaling pathway (GO:0060337) | 3.01659257 |
| 67 | myeloid cell activation involved in immune response (GO:0002275) | 2.98935335 |
| 68 | T cell costimulation (GO:0031295) | 2.98322247 |
| 69 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.97126315 |
| 70 | detection of molecule of bacterial origin (GO:0032490) | 2.94514031 |
| 71 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.93520433 |
| 72 | NIK/NF-kappaB signaling (GO:0038061) | 2.91257700 |
| 73 | lymphocyte costimulation (GO:0031294) | 2.91173010 |
| 74 | positive regulation of lamellipodium assembly (GO:0010592) | 2.90333960 |
| 75 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.90229379 |
| 76 | respiratory burst (GO:0045730) | 2.90135785 |
| 77 | regulation of mast cell activation (GO:0033003) | 2.88649236 |
| 78 | neutrophil activation involved in immune response (GO:0002283) | 2.88621538 |
| 79 | actin nucleation (GO:0045010) | 2.88411469 |
| 80 | negative regulation of T cell mediated immunity (GO:0002710) | 2.87733603 |
| 81 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.86223601 |
| 82 | response to host immune response (GO:0052572) | 2.85909817 |
| 83 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.85909817 |
| 84 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.85855432 |
| 85 | T cell receptor signaling pathway (GO:0050852) | 2.85499723 |
| 86 | endothelial tube morphogenesis (GO:0061154) | 2.85303210 |
| 87 | morphogenesis of an endothelium (GO:0003159) | 2.85303210 |
| 88 | negative regulation of innate immune response (GO:0045824) | 2.84546660 |
| 89 | sequestering of actin monomers (GO:0042989) | 2.83595280 |
| 90 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.82509470 |
| 91 | regulation of T cell tolerance induction (GO:0002664) | 2.82168930 |
| 92 | positive regulation of mast cell activation (GO:0033005) | 2.81155158 |
| 93 | regulation of regulated secretory pathway (GO:1903305) | 2.80870664 |
| 94 | neutrophil activation (GO:0042119) | 2.80452594 |
| 95 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.80367240 |
| 96 | regulation of response to interferon-gamma (GO:0060330) | 2.76823614 |
| 97 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.76609287 |
| 98 | B cell mediated immunity (GO:0019724) | 2.72732061 |
| 99 | negative regulation of interleukin-12 production (GO:0032695) | 2.72597945 |
| 100 | positive regulation of interleukin-2 production (GO:0032743) | 2.72510491 |
| 101 | natural killer cell differentiation (GO:0001779) | 2.72316438 |
| 102 | response to host (GO:0075136) | 2.70395165 |
| 103 | response to host defenses (GO:0052200) | 2.70395165 |
| 104 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.70395165 |
| 105 | positive regulation of isotype switching (GO:0045830) | 2.69553152 |
| 106 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.69362691 |
| 107 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.69233989 |
| 108 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.67817263 |
| 109 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.66914734 |
| 110 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.62780228 |
| 111 | macrophage activation (GO:0042116) | 2.61988740 |
| 112 | negative regulation of interleukin-6 production (GO:0032715) | 2.61814330 |
| 113 | T cell homeostasis (GO:0043029) | 2.61613633 |
| 114 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.61594323 |
| 115 | positive regulation of lamellipodium organization (GO:1902745) | 2.60756550 |
| 116 | lymphocyte homeostasis (GO:0002260) | 2.59993474 |
| 117 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.59861620 |
| 118 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.59740257 |
| 119 | response to muramyl dipeptide (GO:0032495) | 2.59302649 |
| 120 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.58931293 |
| 121 | granulocyte activation (GO:0036230) | 2.58334466 |
| 122 | regulation of protein heterodimerization activity (GO:0043497) | 2.57080133 |
| 123 | positive regulation of mast cell degranulation (GO:0043306) | 2.56616945 |
| 124 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.56616945 |
| 125 | ribosomal small subunit assembly (GO:0000028) | 2.56258072 |
| 126 | leukocyte degranulation (GO:0043299) | 2.54962075 |
| 127 | activated T cell proliferation (GO:0050798) | 2.54918008 |
| 128 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.53911939 |
| 129 | positive regulation of tolerance induction (GO:0002645) | 2.53856303 |
| 130 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.53757142 |
| 131 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.53671483 |
| 132 | positive regulation of type 2 immune response (GO:0002830) | 2.52733000 |
| 133 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.51369953 |
| 134 | DNA unwinding involved in DNA replication (GO:0006268) | 2.50514090 |
| 135 | positive regulation of histone deacetylation (GO:0031065) | 2.50053542 |
| 136 | T cell proliferation (GO:0042098) | 2.49705994 |
| 137 | mast cell activation (GO:0045576) | 2.48302300 |
| 138 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.44412451 |
| 139 | mature B cell differentiation (GO:0002335) | 2.44319558 |
| 140 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.44099254 |
| 141 | natural killer cell activation (GO:0030101) | 2.44059096 |
| 142 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.43310850 |
| 143 | T cell apoptotic process (GO:0070231) | 2.41363861 |
| 144 | B cell homeostasis (GO:0001782) | 2.41254268 |
| 145 | response to laminar fluid shear stress (GO:0034616) | 2.40816709 |
| 146 | pinocytosis (GO:0006907) | 2.40748630 |
| 147 | barbed-end actin filament capping (GO:0051016) | 2.39242767 |
| 148 | myeloid dendritic cell activation (GO:0001773) | 2.38922960 |
| 149 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.38138815 |
| 150 | angiogenesis involved in wound healing (GO:0060055) | 2.36806315 |
| 151 | negative regulation of stress fiber assembly (GO:0051497) | 2.34247320 |
| 152 | positive regulation of macrophage differentiation (GO:0045651) | 2.31641597 |
| 153 | regulation of tolerance induction (GO:0002643) | 2.30014231 |
| 154 | mononuclear cell proliferation (GO:0032943) | 2.29048745 |
| 155 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.28796224 |
| 156 | viral transcription (GO:0019083) | 2.28784321 |
| 157 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.27780453 |
| 158 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.27681976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.76283974 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.89783702 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.75151570 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.67511431 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.49751700 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.30408351 |
| 7 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.95625102 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.92237969 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.85377563 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.76719624 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.74966253 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.69404682 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.62000635 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.61380094 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.58299127 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.42404200 |
| 17 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.38334621 |
| 18 | * MYB_26560356_Chip-Seq_TH2_Human | 2.34213416 |
| 19 | UTX_26944678_Chip-Seq_JUKART_Human | 2.24040154 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.19160976 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.17597006 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.17557426 |
| 23 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.10783609 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.09576373 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.07184355 |
| 26 | MYB_26560356_Chip-Seq_TH1_Human | 2.06677077 |
| 27 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03529792 |
| 28 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03284195 |
| 29 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02051628 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.01670175 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.00632556 |
| 32 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.00110316 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.99213475 |
| 34 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.97448490 |
| 35 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.95823238 |
| 36 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91339811 |
| 37 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89035698 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.86139762 |
| 39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.84017871 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.82392008 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.81048128 |
| 42 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.77794645 |
| 43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.72108992 |
| 44 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.66891751 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.66747003 |
| 46 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.65599705 |
| 47 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.65204304 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60411827 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60212958 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.60205870 |
| 51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.54968649 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54561421 |
| 53 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54269380 |
| 54 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.53693203 |
| 55 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.48776949 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.48154852 |
| 57 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.45459403 |
| 58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.45017217 |
| 59 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44183200 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40101238 |
| 61 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.36571005 |
| 62 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.35047658 |
| 63 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.34442633 |
| 64 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.33702483 |
| 65 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.33234138 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.31645659 |
| 67 | P68_20966046_ChIP-Seq_HELA_Human | 1.29072396 |
| 68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29003980 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27560847 |
| 70 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.26600405 |
| 71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25584258 |
| 72 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22784184 |
| 73 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22750241 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.22143006 |
| 75 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.21684922 |
| 76 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.19951577 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18386464 |
| 78 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17082747 |
| 79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.16613520 |
| 80 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15062083 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14263856 |
| 82 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13122502 |
| 83 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.13098801 |
| 84 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.12833993 |
| 85 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10350957 |
| 86 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.10012895 |
| 87 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.09789669 |
| 88 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08293073 |
| 89 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07677076 |
| 90 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07546261 |
| 91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05927704 |
| 92 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05304790 |
| 93 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.04649500 |
| 94 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04489300 |
| 95 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.03582232 |
| 96 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03210652 |
| 97 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02883972 |
| 98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02855114 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02398548 |
| 100 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.01595117 |
| 101 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.01502344 |
| 102 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98939268 |
| 103 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.96789618 |
| 104 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.96644731 |
| 105 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.95887571 |
| 106 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94417188 |
| 107 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.94350186 |
| 108 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.94235744 |
| 109 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.93215413 |
| 110 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93028897 |
| 111 | SA1_27219007_Chip-Seq_Bcells_Human | 0.93002796 |
| 112 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92982890 |
| 113 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.92909614 |
| 114 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.92042410 |
| 115 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91561679 |
| 116 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88844183 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85873790 |
| 118 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85195300 |
| 119 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.85173194 |
| 120 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.84839121 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83716552 |
| 122 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.80222117 |
| 123 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79294717 |
| 124 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77897007 |
| 125 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77821686 |
| 126 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77739850 |
| 127 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.77306228 |
| 128 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76563465 |
| 129 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.76392519 |
| 130 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75327969 |
| 131 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.75243750 |
| 132 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.74395234 |
| 133 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73960733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.41875728 |
| 2 | MP0000685_abnormal_immune_system | 3.03003761 |
| 3 | MP0003763_abnormal_thymus_physiology | 2.91706110 |
| 4 | MP0001800_abnormal_humoral_immune | 2.91691214 |
| 5 | MP0005671_abnormal_response_to | 2.77206368 |
| 6 | MP0005387_immune_system_phenotype | 2.69150444 |
| 7 | MP0001790_abnormal_immune_system | 2.69150444 |
| 8 | MP0003436_decreased_susceptibility_to | 2.65354314 |
| 9 | MP0003303_peritoneal_inflammation | 2.59038556 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.58263572 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.52202298 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.52007948 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.48314405 |
| 14 | MP0001819_abnormal_immune_cell | 2.44794099 |
| 15 | MP0002398_abnormal_bone_marrow | 2.37227560 |
| 16 | MP0002723_abnormal_immune_serum | 2.35591249 |
| 17 | MP0009785_altered_susceptibility_to | 2.24876754 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.22108921 |
| 19 | MP0010352_gastrointestinal_tract_polyps | 2.20342542 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.15554327 |
| 21 | MP0005025_abnormal_response_to | 2.15055334 |
| 22 | MP0002405_respiratory_system_inflammati | 2.12574926 |
| 23 | MP0009278_abnormal_bone_marrow | 2.11454623 |
| 24 | MP0002419_abnormal_innate_immunity | 2.11403110 |
| 25 | MP0000716_abnormal_immune_system | 2.10429343 |
| 26 | MP0008260_abnormal_autophagy | 2.01642757 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.97580001 |
| 28 | MP0000689_abnormal_spleen_morphology | 1.97536308 |
| 29 | MP0002722_abnormal_immune_system | 1.96982522 |
| 30 | MP0004808_abnormal_hematopoietic_stem | 1.91881094 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.82326829 |
| 32 | MP0002429_abnormal_blood_cell | 1.82213393 |
| 33 | MP0000703_abnormal_thymus_morphology | 1.81233602 |
| 34 | MP0002933_joint_inflammation | 1.80157276 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.79742698 |
| 36 | MP0001873_stomach_inflammation | 1.79243890 |
| 37 | MP0002006_tumorigenesis | 1.76577905 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.74648885 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.74203775 |
| 40 | MP0001853_heart_inflammation | 1.66631108 |
| 41 | MP0000858_altered_metastatic_potential | 1.66002338 |
| 42 | MP0004947_skin_inflammation | 1.65473028 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.64769151 |
| 44 | MP0003866_abnormal_defecation | 1.62269850 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.61344939 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.61344939 |
| 47 | MP0009840_abnormal_foam_cell | 1.57456483 |
| 48 | MP0004510_myositis | 1.52466270 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.51731463 |
| 50 | MP0003693_abnormal_embryo_hatching | 1.49290487 |
| 51 | MP0003279_aneurysm | 1.48198185 |
| 52 | MP0006082_CNS_inflammation | 1.47129240 |
| 53 | MP0000490_abnormal_crypts_of | 1.47094447 |
| 54 | MP0003448_altered_tumor_morphology | 1.46877413 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.45413962 |
| 56 | MP0005076_abnormal_cell_differentiation | 1.40963445 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.34905244 |
| 58 | MP0005023_abnormal_wound_healing | 1.34390259 |
| 59 | MP0004381_abnormal_hair_follicle | 1.32389541 |
| 60 | MP0003077_abnormal_cell_cycle | 1.31586221 |
| 61 | MP0003705_abnormal_hypodermis_morpholog | 1.31448381 |
| 62 | MP0005451_abnormal_body_composition | 1.30881525 |
| 63 | MP0010307_abnormal_tumor_latency | 1.28803084 |
| 64 | MP0005174_abnormal_tail_pigmentation | 1.25147817 |
| 65 | MP0006054_spinal_hemorrhage | 1.24439852 |
| 66 | MP0008438_abnormal_cutaneous_collagen | 1.24031483 |
| 67 | MP0002019_abnormal_tumor_incidence | 1.17407407 |
| 68 | MP0003724_increased_susceptibility_to | 1.15855564 |
| 69 | MP0010094_abnormal_chromosome_stability | 1.15392100 |
| 70 | MP0003111_abnormal_nucleus_morphology | 1.15253584 |
| 71 | MP0005409_darkened_coat_color | 1.14977144 |
| 72 | MP0003183_abnormal_peptide_metabolism | 1.10943773 |
| 73 | MP0001958_emphysema | 1.06332168 |
| 74 | MP0000604_amyloidosis | 1.05635525 |
| 75 | MP0009764_decreased_sensitivity_to | 1.04849879 |
| 76 | MP0008057_abnormal_DNA_replication | 1.04093034 |
| 77 | MP0003690_abnormal_glial_cell | 1.03699331 |
| 78 | MP0001348_abnormal_lacrimal_gland | 1.02895246 |
| 79 | MP0004957_abnormal_blastocyst_morpholog | 1.02492120 |
| 80 | MP0003091_abnormal_cell_migration | 1.00536682 |
| 81 | MP0000569_abnormal_digit_pigmentation | 1.00490166 |
| 82 | MP0002138_abnormal_hepatobiliary_system | 1.00334672 |
| 83 | MP0003075_altered_response_to | 0.99934539 |
| 84 | MP0003172_abnormal_lysosome_physiology | 0.99559598 |
| 85 | MP0004858_abnormal_nervous_system | 0.91280485 |
| 86 | MP0001849_ear_inflammation | 0.90466253 |
| 87 | MP0000350_abnormal_cell_proliferation | 0.89792839 |
| 88 | MP0005166_decreased_susceptibility_to | 0.88793566 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.88285666 |
| 90 | MP0000343_altered_response_to | 0.87746854 |
| 91 | MP0003828_pulmonary_edema | 0.86766544 |
| 92 | MP0004883_abnormal_blood_vessel | 0.86012741 |
| 93 | MP0002254_reproductive_system_inflammat | 0.83901259 |
| 94 | MP0008469_abnormal_protein_level | 0.83353939 |
| 95 | MP0001986_abnormal_taste_sensitivity | 0.82515724 |
| 96 | MP0001730_embryonic_growth_arrest | 0.79227619 |
| 97 | MP0003045_fibrosis | 0.79063346 |
| 98 | MP0000767_abnormal_smooth_muscle | 0.78107616 |
| 99 | MP0005390_skeleton_phenotype | 0.76306522 |
| 100 | MP0008007_abnormal_cellular_replicative | 0.74771749 |
| 101 | MP0000733_abnormal_muscle_development | 0.74605187 |
| 102 | MP0000477_abnormal_intestine_morphology | 0.73954661 |
| 103 | MP0005058_abnormal_lysosome_morphology | 0.72494194 |
| 104 | MP0000313_abnormal_cell_death | 0.71185916 |
| 105 | MP0005310_abnormal_salivary_gland | 0.70085879 |
| 106 | MP0003453_abnormal_keratinocyte_physiol | 0.69186620 |
| 107 | MP0005381_digestive/alimentary_phenotyp | 0.68440002 |
| 108 | MP0001243_abnormal_dermal_layer | 0.66893281 |
| 109 | MP0003795_abnormal_bone_structure | 0.64381896 |
| 110 | MP0001851_eye_inflammation | 0.63698724 |
| 111 | MP0008004_abnormal_stomach_pH | 0.63321525 |
| 112 | MP0005621_abnormal_cell_physiology | 0.62928075 |
| 113 | MP0005075_abnormal_melanosome_morpholog | 0.62434943 |
| 114 | MP0000015_abnormal_ear_pigmentation | 0.60869571 |
| 115 | MP0000249_abnormal_blood_vessel | 0.60867767 |
| 116 | MP0002132_abnormal_respiratory_system | 0.60853622 |
| 117 | MP0002086_abnormal_extraembryonic_tissu | 0.60410443 |
| 118 | MP0005360_urolithiasis | 0.59578980 |
| 119 | MP0000371_diluted_coat_color | 0.58907326 |
| 120 | MP0008874_decreased_physiological_sensi | 0.58806596 |
| 121 | MP0002653_abnormal_ependyma_morphology | 0.57864346 |
| 122 | MP0001542_abnormal_bone_strength | 0.57536312 |
| 123 | MP0002925_abnormal_cardiovascular_devel | 0.56659628 |
| 124 | MP0001663_abnormal_digestive_system | 0.55567442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.52712231 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.20416713 |
| 3 | Recurrent fungal infections (HP:0002841) | 3.85698869 |
| 4 | IgM deficiency (HP:0002850) | 3.84120730 |
| 5 | Recurrent viral infections (HP:0004429) | 3.75504235 |
| 6 | Cellulitis (HP:0100658) | 3.70234149 |
| 7 | Recurrent bronchitis (HP:0002837) | 3.68961441 |
| 8 | T lymphocytopenia (HP:0005403) | 3.68487265 |
| 9 | Abnormality of T cell number (HP:0011839) | 3.55389784 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.54990658 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.47381220 |
| 12 | Myositis (HP:0100614) | 3.31148795 |
| 13 | Agammaglobulinemia (HP:0004432) | 3.17078695 |
| 14 | Thin bony cortex (HP:0002753) | 3.14241925 |
| 15 | Meningitis (HP:0001287) | 3.12569926 |
| 16 | Spontaneous hematomas (HP:0007420) | 3.10937772 |
| 17 | Autoimmune thrombocytopenia (HP:0001973) | 3.10732736 |
| 18 | Abnormality of T cells (HP:0002843) | 3.07792437 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 3.01404468 |
| 20 | Increased cerebral lipofuscin (HP:0011813) | 3.01206699 |
| 21 | Chronic otitis media (HP:0000389) | 3.00435060 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 2.97909696 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.94698774 |
| 24 | Dysostosis multiplex (HP:0000943) | 2.93754208 |
| 25 | Panhypogammaglobulinemia (HP:0003139) | 2.91822120 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 2.91441223 |
| 27 | Obstructive lung disease (HP:0006536) | 2.91441223 |
| 28 | Inflammation of the large intestine (HP:0002037) | 2.87861640 |
| 29 | Gastrointestinal inflammation (HP:0004386) | 2.87821606 |
| 30 | Abnormality of glycolipid metabolism (HP:0010969) | 2.86057145 |
| 31 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.86057145 |
| 32 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.86057145 |
| 33 | Pustule (HP:0200039) | 2.85776622 |
| 34 | Lymphopenia (HP:0001888) | 2.85082232 |
| 35 | Abnormality of B cell number (HP:0010975) | 2.83419860 |
| 36 | B lymphocytopenia (HP:0010976) | 2.83419860 |
| 37 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.82919591 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 2.75591103 |
| 39 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.75591103 |
| 40 | Thrombocytosis (HP:0001894) | 2.74281631 |
| 41 | Combined immunodeficiency (HP:0005387) | 2.73414877 |
| 42 | Verrucae (HP:0200043) | 2.71449513 |
| 43 | Papilloma (HP:0012740) | 2.71449513 |
| 44 | Increased IgE level (HP:0003212) | 2.69412134 |
| 45 | Thyroiditis (HP:0100646) | 2.68797940 |
| 46 | Nasal polyposis (HP:0100582) | 2.68183074 |
| 47 | Severe combined immunodeficiency (HP:0004430) | 2.63640603 |
| 48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.61115590 |
| 49 | Emphysema (HP:0002097) | 2.60357507 |
| 50 | Abnormality of the nasal mucosa (HP:0000433) | 2.60039765 |
| 51 | Gastrointestinal stroma tumor (HP:0100723) | 2.59912578 |
| 52 | Abnormality of the fingertips (HP:0001211) | 2.59249845 |
| 53 | Vasculitis (HP:0002633) | 2.57066407 |
| 54 | Eosinophilia (HP:0001880) | 2.56957119 |
| 55 | Recurrent skin infections (HP:0001581) | 2.54961368 |
| 56 | Abnormality of the peritoneum (HP:0002585) | 2.54767158 |
| 57 | Colitis (HP:0002583) | 2.53083846 |
| 58 | Stomatitis (HP:0010280) | 2.50141047 |
| 59 | Gingivitis (HP:0000230) | 2.50092130 |
| 60 | Systemic lupus erythematosus (HP:0002725) | 2.49866982 |
| 61 | Leukocytosis (HP:0001974) | 2.46909853 |
| 62 | Loss of speech (HP:0002371) | 2.44915260 |
| 63 | Cerebral aneurysm (HP:0004944) | 2.43740546 |
| 64 | Abnormality of macrophages (HP:0004311) | 2.42412642 |
| 65 | Abnormality of T cell physiology (HP:0011840) | 2.41219061 |
| 66 | Osteomyelitis (HP:0002754) | 2.37200129 |
| 67 | Increased density of long bones (HP:0006392) | 2.35987224 |
| 68 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.34047196 |
| 69 | Abnormality of eosinophils (HP:0001879) | 2.33783668 |
| 70 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.31082814 |
| 71 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.31082814 |
| 72 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.31082814 |
| 73 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.28413904 |
| 74 | Aortic aneurysm (HP:0004942) | 2.28382910 |
| 75 | Mucopolysacchariduria (HP:0008155) | 2.27006423 |
| 76 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.27006423 |
| 77 | Epistaxis (HP:0000421) | 2.26896863 |
| 78 | Abnormal platelet volume (HP:0011876) | 2.25883556 |
| 79 | IgA deficiency (HP:0002720) | 2.25864109 |
| 80 | Granulocytopenia (HP:0001913) | 2.25185081 |
| 81 | Ocular albinism (HP:0001107) | 2.24738117 |
| 82 | Peritonitis (HP:0002586) | 2.24046292 |
| 83 | Orchitis (HP:0100796) | 2.22144562 |
| 84 | Malnutrition (HP:0004395) | 2.21704996 |
| 85 | Chest pain (HP:0100749) | 2.20426996 |
| 86 | Hematochezia (HP:0002573) | 2.20345193 |
| 87 | Amyloidosis (HP:0011034) | 2.20079297 |
| 88 | IgG deficiency (HP:0004315) | 2.18513870 |
| 89 | Interstitial pulmonary disease (HP:0006530) | 2.18033966 |
| 90 | Obstructive sleep apnea (HP:0002870) | 2.16414878 |
| 91 | Lymphoma (HP:0002665) | 2.13575015 |
| 92 | Gingival bleeding (HP:0000225) | 2.13183189 |
| 93 | Skin ulcer (HP:0200042) | 2.12623210 |
| 94 | Restrictive lung disease (HP:0002091) | 2.12268125 |
| 95 | Sepsis (HP:0100806) | 2.11834281 |
| 96 | Periodontitis (HP:0000704) | 2.09741334 |
| 97 | Premature loss of primary teeth (HP:0006323) | 2.06300073 |
| 98 | Hemoptysis (HP:0002105) | 2.05148039 |
| 99 | Petechiae (HP:0000967) | 2.02928475 |
| 100 | Basal cell carcinoma (HP:0002671) | 2.02733160 |
| 101 | Recurrent sinusitis (HP:0011108) | 2.02417299 |
| 102 | Purpura (HP:0000979) | 2.01834666 |
| 103 | Bicuspid aortic valve (HP:0001647) | 2.01334996 |
| 104 | Spondylolisthesis (HP:0003302) | 1.99650439 |
| 105 | Aortic dissection (HP:0002647) | 1.99597702 |
| 106 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.99512271 |
| 107 | Short 4th metacarpal (HP:0010044) | 1.99512271 |
| 108 | Recurrent lower respiratory tract infections (HP:0002783) | 1.98773147 |
| 109 | Thoracic kyphosis (HP:0002942) | 1.96346594 |
| 110 | Keratoconjunctivitis sicca (HP:0001097) | 1.96152543 |
| 111 | Pulmonary infiltrates (HP:0002113) | 1.94415429 |
| 112 | Arterial thrombosis (HP:0004420) | 1.93942669 |
| 113 | Protrusio acetabuli (HP:0003179) | 1.93895222 |
| 114 | Chronic diarrhea (HP:0002028) | 1.92361158 |
| 115 | Metaphyseal cupping (HP:0003021) | 1.92018142 |
| 116 | Optic neuritis (HP:0100653) | 1.91001503 |
| 117 | Retrobulbar optic neuritis (HP:0100654) | 1.91001503 |
| 118 | Broad face (HP:0000283) | 1.90781303 |
| 119 | Recurrent pneumonia (HP:0006532) | 1.90738193 |
| 120 | Dilatation of the ascending aorta (HP:0005111) | 1.90482695 |
| 121 | Encephalitis (HP:0002383) | 1.87739116 |
| 122 | Polygenic inheritance (HP:0010982) | 1.85971141 |
| 123 | Increased mean platelet volume (HP:0011877) | 1.85787485 |
| 124 | Prolonged bleeding time (HP:0003010) | 1.83321224 |
| 125 | Episodic fever (HP:0001954) | 1.82729511 |
| 126 | Chronic sinusitis (HP:0011109) | 1.81470920 |
| 127 | Keratoconjunctivitis (HP:0001096) | 1.80856467 |
| 128 | Bronchitis (HP:0012387) | 1.80463375 |
| 129 | Hypochromic anemia (HP:0001931) | 1.79437905 |
| 130 | Iris hypopigmentation (HP:0007730) | 1.79436268 |
| 131 | Ankle contracture (HP:0006466) | 1.79424611 |
| 132 | Vacuolated lymphocytes (HP:0001922) | 1.75226844 |
| 133 | Ulnar bowing (HP:0003031) | 1.75145307 |
| 134 | Persistence of primary teeth (HP:0006335) | 1.74543470 |
| 135 | Hyperacusis (HP:0010780) | 1.72744216 |
| 136 | Hypergammaglobulinemia (HP:0010702) | 1.72475304 |
| 137 | Urticaria (HP:0001025) | 1.71758002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.10556719 |
| 2 | MAP3K10 | 3.13553509 |
| 3 | PRPF4B | 2.83721463 |
| 4 | EEF2K | 2.76675007 |
| 5 | STK10 | 2.72975505 |
| 6 | GRK6 | 2.41403090 |
| 7 | TRIB3 | 2.40945750 |
| 8 | PKN2 | 2.27567526 |
| 9 | BLK | 2.23423129 |
| 10 | JAK3 | 2.21112549 |
| 11 | TXK | 2.17426328 |
| 12 | ZAP70 | 2.15975021 |
| 13 | ITK | 2.09017483 |
| 14 | ERN1 | 2.06954498 |
| 15 | LRRK2 | 1.98398440 |
| 16 | TYK2 | 1.93279880 |
| 17 | BTK | 1.89910944 |
| 18 | KIT | 1.65992302 |
| 19 | TTN | 1.63874918 |
| 20 | CSK | 1.62940091 |
| 21 | IRAK4 | 1.57537789 |
| 22 | CDK12 | 1.56687077 |
| 23 | CSF1R | 1.55198525 |
| 24 | CDC42BPA | 1.53395829 |
| 25 | TEC | 1.52538890 |
| 26 | TBK1 | 1.52262135 |
| 27 | JAK1 | 1.51265395 |
| 28 | MARK2 | 1.50471666 |
| 29 | SYK | 1.43258316 |
| 30 | FGFR4 | 1.41085353 |
| 31 | PRKD2 | 1.40147419 |
| 32 | HCK | 1.36557488 |
| 33 | TESK2 | 1.34831618 |
| 34 | MAP3K14 | 1.27583854 |
| 35 | LCK | 1.27484472 |
| 36 | EPHB1 | 1.26586875 |
| 37 | FGFR3 | 1.25978978 |
| 38 | SIK2 | 1.22526012 |
| 39 | RPS6KA4 | 1.21942800 |
| 40 | IKBKE | 1.19806515 |
| 41 | CLK1 | 1.19707532 |
| 42 | RIPK4 | 1.18776431 |
| 43 | MAP2K3 | 1.16876784 |
| 44 | PIM1 | 1.16198281 |
| 45 | NEK2 | 1.13860849 |
| 46 | MAP3K6 | 1.13791640 |
| 47 | MARK3 | 1.12893139 |
| 48 | TGFBR2 | 1.11008150 |
| 49 | KSR2 | 1.04056629 |
| 50 | PTK6 | 1.01372844 |
| 51 | MAP3K3 | 0.99715493 |
| 52 | MAPK7 | 0.98456120 |
| 53 | KDR | 0.96107320 |
| 54 | IKBKB | 0.95569385 |
| 55 | FLT3 | 0.95288137 |
| 56 | MAP3K1 | 0.94230387 |
| 57 | TRPM7 | 0.92613827 |
| 58 | CDK4 | 0.91223347 |
| 59 | MST4 | 0.89370229 |
| 60 | SMG1 | 0.88650899 |
| 61 | CDC7 | 0.87810114 |
| 62 | LYN | 0.87246717 |
| 63 | MAPK12 | 0.86830211 |
| 64 | MAP3K8 | 0.86801424 |
| 65 | RPS6KA2 | 0.86518600 |
| 66 | NLK | 0.85007769 |
| 67 | PAK4 | 0.84607987 |
| 68 | CAMKK1 | 0.82682371 |
| 69 | FES | 0.82664615 |
| 70 | MAP3K13 | 0.80523805 |
| 71 | PDPK1 | 0.80322221 |
| 72 | ICK | 0.79770374 |
| 73 | RPS6KB2 | 0.77131613 |
| 74 | IRAK3 | 0.76643705 |
| 75 | STK4 | 0.74144968 |
| 76 | CHUK | 0.70367413 |
| 77 | TYRO3 | 0.68537524 |
| 78 | DYRK1B | 0.67777739 |
| 79 | HIPK2 | 0.66936107 |
| 80 | NME2 | 0.66578214 |
| 81 | SGK3 | 0.66356651 |
| 82 | TESK1 | 0.65196937 |
| 83 | CDK6 | 0.65195007 |
| 84 | ALK | 0.65088240 |
| 85 | EPHA3 | 0.63733554 |
| 86 | DDR2 | 0.63014581 |
| 87 | DAPK2 | 0.61910079 |
| 88 | TGFBR1 | 0.61626252 |
| 89 | MATK | 0.60906707 |
| 90 | MOS | 0.60708093 |
| 91 | MAP3K11 | 0.59031526 |
| 92 | JAK2 | 0.58530711 |
| 93 | MAP2K6 | 0.57934094 |
| 94 | PRKCH | 0.56921825 |
| 95 | PRKCQ | 0.56075787 |
| 96 | PDGFRB | 0.54311181 |
| 97 | RPS6KA6 | 0.54001644 |
| 98 | TAOK2 | 0.53911525 |
| 99 | SCYL2 | 0.53503866 |
| 100 | DMPK | 0.53421599 |
| 101 | MAPKAPK2 | 0.52986449 |
| 102 | NEK9 | 0.52782547 |
| 103 | RET | 0.50862170 |
| 104 | IRAK1 | 0.50682922 |
| 105 | MAP3K7 | 0.48867034 |
| 106 | SGK2 | 0.48646937 |
| 107 | ILK | 0.48363327 |
| 108 | RPS6KL1 | 0.47508540 |
| 109 | RPS6KC1 | 0.47508540 |
| 110 | PDGFRA | 0.46280874 |
| 111 | CDK19 | 0.46036051 |
| 112 | RIPK1 | 0.44544889 |
| 113 | CDK7 | 0.44532724 |
| 114 | MAPKAPK3 | 0.43431897 |
| 115 | TAOK1 | 0.42996906 |
| 116 | IRAK2 | 0.42991060 |
| 117 | YES1 | 0.42573472 |
| 118 | MAPK11 | 0.41746773 |
| 119 | FGR | 0.40585199 |
| 120 | SIK3 | 0.40305518 |
| 121 | PTK2B | 0.39334335 |
| 122 | PRKG2 | 0.38664599 |
| 123 | STK11 | 0.38568611 |
| 124 | MELK | 0.38192819 |
| 125 | ARAF | 0.38181399 |
| 126 | SIK1 | 0.37783572 |
| 127 | ATR | 0.36796335 |
| 128 | BMX | 0.36395522 |
| 129 | STK24 | 0.36226689 |
| 130 | TNK2 | 0.35337514 |
| 131 | PIM2 | 0.34460779 |
| 132 | PDK1 | 0.32638983 |
| 133 | FYN | 0.32279264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.53247457 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.49261487 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.39081905 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.11500191 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.08150355 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.00833652 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.00487190 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.98436986 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.88164608 |
| 10 | Measles_Homo sapiens_hsa05162 | 1.87655202 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.87487234 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.87148143 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.83937035 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.81493736 |
| 15 | DNA replication_Homo sapiens_hsa03030 | 1.80341939 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.74585616 |
| 17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.70417882 |
| 18 | Shigellosis_Homo sapiens_hsa05131 | 1.61077658 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.59382205 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.56358295 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49665268 |
| 22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.46321298 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44708869 |
| 24 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.44229918 |
| 25 | Apoptosis_Homo sapiens_hsa04210 | 1.39233716 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.36529156 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.36181814 |
| 28 | Mismatch repair_Homo sapiens_hsa03430 | 1.35852570 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35841281 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.27308326 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.26813900 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.23264465 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.23255754 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22987891 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.22816619 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.21510819 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20272848 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.20089383 |
| 39 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.16668758 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15102168 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14637696 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.13220474 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.12773512 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 1.12627361 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.12451924 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 1.12407550 |
| 47 | HTLV-I infection_Homo sapiens_hsa05166 | 1.11712855 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.09793535 |
| 49 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.07668602 |
| 50 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.06602046 |
| 51 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.05929580 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.05469457 |
| 53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01897073 |
| 54 | Ribosome_Homo sapiens_hsa03010 | 1.00642141 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.99991375 |
| 56 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99465286 |
| 57 | Malaria_Homo sapiens_hsa05144 | 0.98244872 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.96283959 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.96181201 |
| 60 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.95541117 |
| 61 | Colorectal cancer_Homo sapiens_hsa05210 | 0.94971973 |
| 62 | Spliceosome_Homo sapiens_hsa03040 | 0.94480563 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93096030 |
| 64 | Cell cycle_Homo sapiens_hsa04110 | 0.92932006 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 0.92725176 |
| 66 | Allograft rejection_Homo sapiens_hsa05330 | 0.92552887 |
| 67 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88544014 |
| 68 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.87485103 |
| 69 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.86844476 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86326192 |
| 71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.84761478 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80626971 |
| 73 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.79705187 |
| 74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79459819 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78195199 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77909306 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76021863 |
| 78 | Focal adhesion_Homo sapiens_hsa04510 | 0.74177324 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72339154 |
| 80 | Adherens junction_Homo sapiens_hsa04520 | 0.72038323 |
| 81 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.71364126 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70650177 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68912881 |
| 84 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.67659261 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67654365 |
| 86 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.66585168 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66276299 |
| 88 | Homologous recombination_Homo sapiens_hsa03440 | 0.66021333 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65710633 |
| 90 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65075074 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64816489 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 0.64019500 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63685252 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61038588 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.59431722 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59311878 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58707953 |
| 98 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58008840 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57482426 |
| 100 | RNA transport_Homo sapiens_hsa03013 | 0.57278423 |
| 101 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.55225082 |
| 102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54449541 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52882852 |
| 104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51351795 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50988525 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50771530 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.50581401 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50381419 |
| 109 | Lysosome_Homo sapiens_hsa04142 | 0.49993441 |
| 110 | Amoebiasis_Homo sapiens_hsa05146 | 0.49786985 |
| 111 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.48499575 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47858508 |
| 113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47830185 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47565265 |
| 115 | Asthma_Homo sapiens_hsa05310 | 0.46820608 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46158628 |
| 117 | Prostate cancer_Homo sapiens_hsa05215 | 0.45830652 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45631444 |
| 119 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.45039770 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.44229468 |
| 121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43820779 |
| 122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43809811 |
| 123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43801316 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.43243357 |
| 125 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39178064 |
| 126 | Glioma_Homo sapiens_hsa05214 | 0.38716186 |

